Platelet associated complement components (PAC3cand PAC3d) in patients with autoimmune thrombocytopenia

Abstract
Platelet associated C3c and C3d [complement components] (PAC3c and PAC3d) were quantitated by enzyme linked assay in 105 patients with idiopathic autoimmune thrombocytopenia (AITP) in whom elevated platelet associated Ig (IgG and IgM) had previously been documented. Increased levels of complement components were demonstrated in 46 of 105 patients (43.8%). In 11 of these patients. PAC3d alone was abnormal implying that C3b was inactivated after cleavage by C3 inactivator in vivo. Complement binding was seen in 2 of 16 patients (12.5%) with raised PAIgG alone, 4 of 19 patients (21.0%) with raised PAIgM alone and in 40 to 70 patients (57.1%) in whom PAIgG and PAIgM were raised together. This difference was highly significant (P = 0.01). The clinical implication of these findings are discussed.